Fibroelastosis Endocardialny

Endocardial fibroelastosis (fibroelastosis endocardialis) is a rare congenital heart disease characterized by thickening of the endocardium, the inner layer of the heart muscle. This pathology mainly manifests itself in young children and can lead to serious circulatory disorders.

Endocardial fibroelastosis occurs in children under 2 years of age and can be detected during the diagnosis of congenital heart defects. The main symptoms of the disease include fatigue, pale skin, palpitations, shortness of breath and growth problems. Some children may also experience arrhythmias and swelling.

The causes of endocardial fibroelastosis are not fully understood, however, it is believed that it is a genetic disease. Children suffering from this disease often have mutations in certain genes involved in heart development.

To diagnose endocardial fibroelastosis, various research methods are used, including ECG, echocardiography and cardiac magnetic resonance imaging. Treatment of the disease may include the use of medications aimed at improving blood circulation, as well as surgery.

Surgical treatment of endocardial fibroelastosis may include surgery to replace the affected area of ​​the endocardium with healthy tissue. Surgeries can also be performed to eliminate congenital heart defects that may accompany endocardial fibroelastosis.

In general, endocardial fibroelastosis is a serious disease that can lead to serious circulatory disorders and requires timely diagnosis and treatment. If you suspect this disease, you must immediately contact a qualified cardiologist for diagnosis and prescribing the necessary treatment.